Thanks, I appreciate the answer with clear explanations.
Yes, I read about the combination giving much better results, but we are not there yet, sadly. Such a shame no large trials have been run over all those years using combo treatment.
"MHRA will (in my opinion) give DCVax-L it's licence and NICE will agree terms with NWBio which will likely be cheaper than the current SOC that Big Pharma charge."
This statement is ridiculous and also impossible. If DCVax ever got an approval, it would be give IN ADDITION TO SOC as an adjuvant, not as a replacement. Therefore making the cost a lot higher to the NHS. You really need to speak to a professional financial advisor before you keep losing money.
Market Data 
Markets 
AI
